Patients’ characteristics of the AAV cohort.

Characteristics of patients with ANCA-associated vasculitis analysed for effects of cyclophosphamide (CYC) and rituximab (RTX).GPA, granulomatosis with polyangiitis (Wegener’s granulomatosis); MPA, microscopic polyangiitis; CSS, Churg-Strauss syndrome; ANCA, antineutrophil cytoplasmic antibody; PR3, proteinase3; MPO, myeloperoxidase; IQR, interquartile range; CYC, cyclophosphamide; RTX, rituximab.If not indicated otherwise, median and interquartile range are reported;#14 patients of CYC analysis group were later treated with RTX and subsequently also enrolled into the RTX analysis group.